Skip to main content

Enovis to Participate in Investor Conferences in November

Wilmington, DE, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two investor conferences in November.

On Tuesday, November 8, Chris Hix, CFO, and Ben Berry, incoming CFO, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA.

On Tuesday, November 29, Matt Trerotola, CEO, and Ben Berry, incoming CFO, will participate in the Evercore ISI 5th Annual HEALTHCONx virtual conference.


Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit


Derek Leckow
Vice President, Investor Relations
Enovis Corporation


Source: Enovis Corporation

Primary Logo

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.